Afuco™ Anti-Human CNR1 ADCC Therapeutic Antibody (RYI-018), ADCC Enhanced
Anti-CNR1 ADCC Enhanced Antibody (RYI-018) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a first in class functional antagonist of Cannabinoid 1 Receptor (CB1), under preclinical development for metabolic and fibrotic indications, NASH, liver fibrosis, kidney fibrosis, metabolic disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-171CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |
| Target | CNR1 |
| Species Reactivity | Human |